California’s Legislation of Dialysis Profit Restriction Could Cause DaVita to Lose Up to $40 Million
DaVita has estimated it could lose up to $40 million in revenue if California’s restricting dialysis profits and use of third-party payers to cover Medicare premiums becomes law. The company spent $30 million in Q4 2018 in an effort to counter union policy efforts and spent $93 million on advocacy efforts last year.Source: Nephrology News & Issues
Life-threatening bleeds (LTB) from arteriovenous fistulas or grafts are significant bleeds which are not stopped by application of a normal amount of pressure as is commonly used to stop bleeding after dialysis needle removal. In many cases they occur spontaneously at home between dialysis sessions, away from the clinic or caregiving team. Although access-related LTBs are not common, they can result in the loss of the patient’s access and even be fatal.
Topics: CABG Surgery, Hemodialysis
